AVNS Q3 2022 Earnings — Avanos Medical, Inc. Revenue & Financial Results | Market Cap Arena

AVNSAvanos Medical, Inc.

$621M

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$172M-6.4% YoY

Gross Profit

$100M58.2% margin

Operating Income

$15M8.7% margin

Net Income

$16M9.1% margin

EPS (Diluted)

$0.33

QoQ Revenue Growth

+0.8%

Cash Flow

Operating Cash Flow

$28M

Free Cash Flow

$23M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$512M

Stockholders' Equity

$1.3B

Cash & Equivalents

$117M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$172M	$184M	-6.4%
Gross Profit	$100M	$92M	+8.9%
Operating Income	$15M	$12M	+28.2%
Net Income	$16M	-$35M	+144.7%

Revenue Segments

Chronic Care

$116M29%

Pain Management

$86M21%

Digestive health

$86M21%

Interventional pain

$48M12%

Acute pain

$39M10%

Respiratory health

$30M7%